Dana Farber Cancer Institute, Harvard Medical School
Disclosure information not submitted.
From Early Immune Surveillance to Immunotherapy: Harnessing Memory-Like NK Cells after Allo-HCT
Friday, April 17, 20263:45 PM - 5:15 PM US ET
